FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313502525> ?p ?o ?g. }

• W4313502525 endingPage "288" @default.
• W4313502525 startingPage "279" @default.
• W4313502525 abstract "Abstract. Purpose: The purpose of this study was the clinical and therapeutic assessment of lower-limb osteosynthesis-associated infection (OAI) by multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacteria (GNB), which have been poorly studied to date. Methods: A prospective multicentre observational study was conducted on behalf of ESGIAI (the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group on Implant-Associated Infections). Factors associated with remission of the infection were evaluated by multivariate and Cox regression analysis for a 24-month follow-up period. Results: Patients (n=57) had a history of trauma (87.7 %), tumour resection (7 %) and other bone lesions (5.3 %). Pathogens included Escherichia coli (n=16), Pseudomonas aeruginosa (n=14; XDR 50 %), Klebsiella spp. (n=7), Enterobacter spp. (n=9), Acinetobacter spp. (n=5), Proteus mirabilis (n=3), Serratia marcescens (n=2) and Stenotrophomonas maltophilia (n=1). The prevalence of ESBL (extended-spectrum β-lactamase), fluoroquinolone and carbapenem resistance were 71.9 %, 59.6 % and 17.5 % respectively. Most patients (n=37; 64.9 %) were treated with a combination including carbapenems (n=32) and colistin (n=11) for a mean of 63.3 d. Implant retention with debridement occurred in early OAI (66.7 %), whereas the infected device was removed in late OAI (70.4 %) (p=0.008). OAI remission was achieved in 29 cases (50.9 %). The type of surgery, antimicrobial resistance and duration of treatment did not significantly influence the outcome. Independent predictors of the failure to eradicate OAI were age >60 years (hazard ratio, HR, of 3.875; 95 % confidence interval, CI95 %, of 1.540–9.752; p=0.004) and multiple surgeries for OAI (HR of 2.822; CI95 % of 1.144–6.963; p=0.024). Conclusions: Only half of the MDR/XDR GNB OAI cases treated by antimicrobials and surgery had a successful outcome. Advanced age and multiple surgeries hampered the eradication of OAI. Optimal therapeutic options remain a challenge." @default.
• W4313502525 created "2023-01-06" @default.
• W4313502525 creator A5009276849 @default.
• W4313502525 creator A5011731216 @default.
• W4313502525 creator A5014925720 @default.
• W4313502525 creator A5018133829 @default.
• W4313502525 creator A5021724884 @default.
• W4313502525 creator A5024874330 @default.
• W4313502525 creator A5025711711 @default.
• W4313502525 creator A5026597427 @default.
• W4313502525 creator A5039742062 @default.
• W4313502525 creator A5042216581 @default.
• W4313502525 creator A5045637502 @default.
• W4313502525 creator A5047732100 @default.
• W4313502525 creator A5048989698 @default.
• W4313502525 creator A5050460594 @default.
• W4313502525 creator A5051192324 @default.
• W4313502525 creator A5051637567 @default.
• W4313502525 creator A5054404021 @default.
• W4313502525 creator A5056852015 @default.
• W4313502525 creator A5057826881 @default.
• W4313502525 creator A5059714838 @default.
• W4313502525 creator A5064459681 @default.
• W4313502525 creator A5065259565 @default.
• W4313502525 creator A5071545285 @default.
• W4313502525 creator A5074132366 @default.
• W4313502525 creator A5081077309 @default.
• W4313502525 date "2022-12-21" @default.
• W4313502525 modified "2023-10-08" @default.
• W4313502525 title "Osteosynthesis-associated infection of the lower limbs by multidrug-resistant and extensively drug-resistant Gram-negative bacteria: a multicentre cohort study" @default.
• W4313502525 cites W159712602 @default.
• W4313502525 cites W1746486625 @default.
• W4313502525 cites W1914001895 @default.
• W4313502525 cites W1981726400 @default.
• W4313502525 cites W2000903526 @default.
• W4313502525 cites W2008413762 @default.
• W4313502525 cites W2026930636 @default.
• W4313502525 cites W2077065923 @default.
• W4313502525 cites W2085469816 @default.
• W4313502525 cites W2119346399 @default.
• W4313502525 cites W2142343447 @default.
• W4313502525 cites W2154366164 @default.
• W4313502525 cites W2155740017 @default.
• W4313502525 cites W2167190508 @default.
• W4313502525 cites W2168292292 @default.
• W4313502525 cites W2260700838 @default.
• W4313502525 cites W2294927917 @default.
• W4313502525 cites W2365841456 @default.
• W4313502525 cites W2417147783 @default.
• W4313502525 cites W2550935043 @default.
• W4313502525 cites W2620587783 @default.
• W4313502525 cites W2747036772 @default.
• W4313502525 cites W2786886659 @default.
• W4313502525 cites W2899385724 @default.
• W4313502525 cites W2911527623 @default.
• W4313502525 cites W2912017198 @default.
• W4313502525 cites W2922796740 @default.
• W4313502525 cites W2960351835 @default.
• W4313502525 cites W2965048578 @default.
• W4313502525 cites W3187121636 @default.
• W4313502525 cites W4241470858 @default.
• W4313502525 doi "https://doi.org/10.5194/jbji-7-279-2022" @default.
• W4313502525 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36644590" @default.
• W4313502525 hasPublicationYear "2022" @default.
• W4313502525 type Work @default.
• W4313502525 citedByCount "0" @default.
• W4313502525 crossrefType "journal-article" @default.
• W4313502525 hasAuthorship W4313502525A5009276849 @default.
• W4313502525 hasAuthorship W4313502525A5011731216 @default.
• W4313502525 hasAuthorship W4313502525A5014925720 @default.
• W4313502525 hasAuthorship W4313502525A5018133829 @default.
• W4313502525 hasAuthorship W4313502525A5021724884 @default.
• W4313502525 hasAuthorship W4313502525A5024874330 @default.
• W4313502525 hasAuthorship W4313502525A5025711711 @default.
• W4313502525 hasAuthorship W4313502525A5026597427 @default.
• W4313502525 hasAuthorship W4313502525A5039742062 @default.
• W4313502525 hasAuthorship W4313502525A5042216581 @default.
• W4313502525 hasAuthorship W4313502525A5045637502 @default.
• W4313502525 hasAuthorship W4313502525A5047732100 @default.
• W4313502525 hasAuthorship W4313502525A5048989698 @default.
• W4313502525 hasAuthorship W4313502525A5050460594 @default.
• W4313502525 hasAuthorship W4313502525A5051192324 @default.
• W4313502525 hasAuthorship W4313502525A5051637567 @default.
• W4313502525 hasAuthorship W4313502525A5054404021 @default.
• W4313502525 hasAuthorship W4313502525A5056852015 @default.
• W4313502525 hasAuthorship W4313502525A5057826881 @default.
• W4313502525 hasAuthorship W4313502525A5059714838 @default.
• W4313502525 hasAuthorship W4313502525A5064459681 @default.
• W4313502525 hasAuthorship W4313502525A5065259565 @default.
• W4313502525 hasAuthorship W4313502525A5071545285 @default.
• W4313502525 hasAuthorship W4313502525A5074132366 @default.
• W4313502525 hasAuthorship W4313502525A5081077309 @default.
• W4313502525 hasBestOaLocation W43135025251 @default.
• W4313502525 hasConcept C104317684 @default.
• W4313502525 hasConcept C114851261 @default.
• W4313502525 hasConcept C126322002 @default.
• W4313502525 hasConcept C133936738 @default.
• W4313502525 hasConcept C141071460 @default.

• next